Physician profile
Gary C Hubbard
NPI 1841249828
$344.46
in general payments reported to CMS, 2019-2025
7 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.61 · 2020: $40.80 · 2022: $27.47 · 2023: $24.03 · 2024: $69.00 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200 · Entertainment: $14.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.68 |
| Entertainment | $14.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $102.41 | 2019-2020 | |
| Apellis Pharmaceuticals, INC. | $66.04 | 2025 | Syfovre |
| Harrow Eye, LLC | $54.30 | 2024 | Vevye |
| Sun Pharmaceutical Industries INC. | $45.46 | 2022-2025 | |
| Optos, INC. | $26.70 | 2022-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $25.52 | 2025 | Rocklatan |
| Novartis Pharmaceuticals Corporation | $24.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Hubbard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.